COMMUNIQUÉS West-GlobeNewswire

Tetra Bio-Pharma Shareholders Approve the Acquisition of Panag Pharma
18/04/2019
Another Important Milestone Will be Achieved with the Closing of this Transaction OTTAWA, April 18, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the "Company" ) (TSX-V: TBP) (OTCQB: TBPMF), is pleased to [...]
Les actionnaires de Tetra Bio-Pharma approuvent l’acquisition de Panag Pharma
18/04/2019
Cette transaction marque un autre jalon important pour l’entreprise OTTAWA, 18 avr. 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (« Tetra » ou la « Société » ) (TSX-V : TBP) (OTCQB : TBPMF) est heureuse d’annoncer qu’ [...]
Helix BioPharma Corp. Closes First Tranche of Private Placement
18/04/2019
RICHMOND HILL, Ontario, April 18, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Suspension, 0.5%
18/04/2019
LAKE FOREST, Ill., April 18, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) [...]
T2 Biosystems Announces 2019 First Quarter Financial and Operational Results Release and Conference Call Date
18/04/2019
LEXINGTON, Mass., April 18, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced [...]
WW Schedules First Quarter 2019 Earnings Conference Call
18/04/2019
NEW YORK, April 18, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (NASDAQ: WTW) (“WW”) will release its results for the first quarter 2019 after market close on Thursday, May 2, 2019. WW will host a [...]
Sientra to Release First Quarter Financial Results on May 8, 2019
18/04/2019
SANTA BARBARA, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company (“Sientra” or the “Company”), announced today that the Company will release its first quarter 2019 [...]
Sol-Gel Technologies Announces Participation in Upcoming Investor Conference
18/04/2019
NESS ZIONA, Israel, April 18, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
Prothena Reports Results from the Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis
18/04/2019
Results from final analysis of the composite primary endpoint were consistent with the futility analysis reported in April 2018 Results from post hoc analyses revealed a potential survival benefit with NEOD001 in the [...]
Aduro Biotech Appoints Experienced Financial Executive, Frank Karbe, to its Board of Directors
18/04/2019
BERKELEY, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical stage biopharmaceutical company developing therapies in the Stimulator of Interferon Genes (STING) and A Proliferation [...]
Dynavax to Present Data on Toll-like Receptor 9 Agonist SD-101 at the ASCO Annual Meeting 2019
18/04/2019
BERKELEY, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology [...]
SeaSpine to Report First Quarter 2019 Financial Results on May 1, 2019
18/04/2019
CARLSBAD, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Corcept Therapeutics to Present Data at the 2019 American Association of Clinical Endocrinologists’ 28th Annual Congress
18/04/2019
MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]
Intuitive Announces First Quarter Earnings
18/04/2019
SUNNYVALE, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (“Intuitive” or the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted [...]
IRIDEX to Report First Quarter 2019 Financial Results on May 2, 2019
18/04/2019
MOUNTAIN VIEW, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the first quarter of 2019 after the close of trading on Thursday [...]
Akorn Receives FDA Approval for Fluticasone Propionate Nasal Spray USP, 50 mcg per spray (OTC)
18/04/2019
LAKE FOREST, Ill., April 18, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) [...]
Adaptimmune Announces Oral Presentation of Allogeneic SPEAR T-cell Program at 2019 ASGCT Meeting
18/04/2019
- Presentation to include overview of substantial progress of Adaptimmune’s off-the-shelf SPEAR T-cell platform - - Data will show that hiPSC-derived allogeneic SPEAR T-cells have a T-cell phenotype and demonstrate [...]
Principia Biopharma Appoints Shao-Lee Lin, M.D., Ph.D. to Board of Directors
18/04/2019
SOUTH SAN FRANCISCO, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
State and Private Partnerships Fund Centering to Improve Infant and Maternal Mortality In New Jersey
18/04/2019
The Nicholson Foundation, The Henry and Marilyn Taub Foundation and The Burke Foundation join New Jersey Department of Health in supporting the implementation of Centering as model of choice across five sites in the [...]

Pages